Can Vaping Cause Strokes? What the Science Says

Vaping is associated with a higher risk of stroke, though the size of that risk and how much of it comes from e-cigarettes alone remain genuinely uncertain. A meta-analysis covering more than a million participants found that current e-cigarette users had roughly 50 percent greater odds of stroke compared with non-users, but former vapers showed no significant increase, and nearly every large study struggles to separate vaping’s effects from the lingering damage of past smoking. The biological plausibility is strong: lab and clinical research shows that e-cigarette aerosol stiffens arteries, impairs the blood vessel lining, and makes blood more prone to clotting. The question is less “could vaping cause a stroke?” and more “how large is the independent risk, and for whom?”

What the Population Studies Actually Show

The strongest statistical snapshot comes from a 2024 meta-analysis that pooled data on over one million people. Current e-cigarette users had about 52 percent higher odds of stroke than non-users. Former e-cigarette users, by contrast, showed no significant increase at all.¹ That gap between current and former users is striking, and it suggests the risk might be reversible, though it could also reflect differences in who quits vaping versus who continues.

A separate analysis using U.S. national health survey data found that sole e-cigarette users had roughly twice the odds of reporting a stroke compared with people who never used tobacco, after adjusting for age, sex, diabetes, high blood pressure, and other known risk factors.² That estimate puts sole e-cigarette use in a similar range to sole cigarette smoking in the same dataset, though the confidence intervals overlap enough that drawing firm comparisons is premature.

Not all studies agree on the magnitude. A large 2025 analysis found that overall e-cigarette users showed no statistically significant stroke increase once smoking history was accounted for, though a subgroup of former smokers who currently vape did have about 73 percent higher odds of stroke than non-users.³ That pattern keeps showing up: the association between vaping and stroke tends to be strongest in people with a smoking history, which makes isolating vaping’s independent contribution extremely difficult.

The Confounding Problem

A systematic review and meta-analysis dedicated to this exact question concluded that the role of e-cigarettes in stroke development is “inconclusive, due to the strong effect of prior tobacco use as a risk factor for stroke in the included studies.”⁴ This is the central difficulty: most adult vapers are current or former cigarette smokers. Cigarette smoking causes well-documented vascular damage that persists for years after quitting. When a study finds higher stroke rates among vapers, it can be genuinely hard to tell whether the culprit is the vaping, the residual damage from prior smoking, or both working together.

Cross-sectional surveys, which are what most of these studies rely on, capture a snapshot in time. They can show that stroke is more common among people who vape, but they cannot prove that vaping caused the stroke. Someone might start vaping after a stroke, for example, or a person’s history of heavy smoking might be doing most of the heavy lifting even though they have since switched to e-cigarettes. Researchers have tried to control for smoking history statistically, but “residual confounding” is a real limitation that no amount of statistical adjustment fully eliminates. The honest read of the epidemiology right now is that there is a signal connecting vaping and stroke, but the signal is muddied by shared risk factors that are hard to strip away.

Dual Use Makes Things Worse

One finding is much clearer: using both e-cigarettes and conventional cigarettes at the same time is worse than using either product alone. An analysis of young adults found that dual users had nearly three times the odds of stroke compared with people who used neither product, and about 1.8 times the odds compared with people who only smoked cigarettes.⁵ A pooled analysis published in NEJM Evidence confirmed this pattern across multiple cardiovascular outcomes, finding that dual users consistently had higher disease odds than cigarette-only smokers, with estimates ranging from 20 to 41 percent higher depending on the outcome.⁶

This matters because dual use is common. Many people pick up e-cigarettes as a way to cut down on smoking but never fully switch, ending up exposed to the harmful components of both products. From a stroke-prevention standpoint, the data strongly suggest that adding vaping on top of smoking is the worst-case scenario, not a harm-reduction strategy.

How Vaping Damages Blood Vessels

Even if the epidemiology is still catching up, the biological mechanisms linking vaping to stroke risk are becoming well documented. Strokes happen when blood flow to the brain is interrupted, either by a clot blocking an artery (ischemic stroke) or a weakened vessel bursting (hemorrhagic stroke). E-cigarette aerosol appears to affect several steps in the chain that leads to both types.

The most immediate effect is on arterial stiffness and blood pressure. A systematic review and meta-analysis of acute exposure studies found that vaping with nicotine significantly increased pulse wave velocity (a measure of how stiff your arteries are) and raised heart rate compared with vaping nicotine-free liquid.⁷ The same review noted that the acute effect of nicotine-containing e-cigarettes on the inner lining of blood vessels was not meaningfully different from that of a conventional cigarette. A study specifically examining pod-style devices confirmed that blood pressure, central arterial pressure, and pulse rate all rose significantly after a vaping session, and the stiffness increases were independent of the user’s sex, age, or which device they used.⁸

Beneath those acute spikes lies a more insidious process: chronic damage to the endothelium, the thin layer of cells lining every blood vessel. Healthy endothelial cells produce nitric oxide, a molecule that keeps arteries relaxed, fights inflammation, and discourages clot formation. Blood serum from habitual e-cigarette users reduced nitric oxide production in lab-grown endothelial cells to a degree similar to serum from cigarette smokers.⁹ Animal studies have traced the mechanism further, showing that e-cigarette exposure triggers a damaging cycle of oxidative stress in the vessel wall that both destroys existing nitric oxide and shuts down its production.¹⁰ Research on tiny particles shed by endothelial cells into the bloodstream confirmed the same pattern in humans: microvesicles from e-cigarette users boosted inflammation markers and cut nitric oxide output when applied to fresh endothelial cells in the lab.¹¹

Blood Clotting Gets Ramped Up

A stroke-prone vascular environment is not just about stiff, inflamed arteries. Blood that clots too easily is the other half of the equation, and e-cigarette exposure appears to push clotting in the wrong direction. A randomized clinical trial in healthy volunteers found that vaping with nicotine significantly increased platelet clumping and fibrin-rich clot formation within 15 minutes, compared with vaping nicotine-free liquid.¹² The effect normalized after about an hour, but for someone vaping repeatedly throughout the day, that brief window of elevated clotting risk keeps reopening.

Mouse studies have filled in more detail. Platelets from e-cigarette-exposed animals were hyperactive across the board, with enhanced aggregation, increased surface signals that promote clotting, and resistance to the body’s natural anti-clotting molecule prostacyclin. The time it took for a clot to fully block a vessel in these animals was dramatically shorter than in unexposed mice.¹³ A follow-up study using JUUL-type devices specifically found similarly shortened clotting times.¹⁴ While mouse physiology is not human physiology, these findings align with the human trial data and provide a plausible mechanism through which vaping could tip someone toward an ischemic stroke.

The Blood-Brain Barrier Angle

The brain has a specialized protective layer called the blood-brain barrier that tightly controls what gets in from the bloodstream. Disruption of this barrier is implicated in stroke severity and in the brain’s ability to recover afterward. In a somewhat surprising finding, mouse studies show that nicotine-free e-cigarette aerosol may be more damaging to the blood-brain barrier than aerosol containing nicotine. Mice exposed to nicotine-free vapor showed increased barrier leakiness, elevated brain inflammation, and impaired performance on memory tests, effects that were not observed in mice exposed to nicotine-containing vapor or even conventional cigarette smoke.¹⁵

A 2025 study extended this work, showing that prolonged exposure to nicotine-free e-cigarette aerosol progressively degraded barrier-forming proteins in both cell cultures and live mice. After 14 days of exposure, mice of both sexes had reduced levels of key tight-junction proteins and elevated levels of multiple pro-inflammatory molecules in the brain.¹⁶ A review paper has proposed that the non-nicotine ingredients in e-liquid exert a pro-inflammatory effect on brain vasculature that nicotine may actually partially counteract, a model that inverts the common assumption that nicotine is always the most dangerous component.¹⁷

It Is Not Just the Nicotine

That finding about nicotine-free vapor being harmful to the blood-brain barrier points to a broader theme in the research: the non-nicotine components of e-cigarette aerosol cause vascular damage on their own. Even among healthy young people who had never smoked, a single session of vaping nicotine-free aerosol caused a measurable spike in blood markers of oxidative stress and inflammation, peaking at about one to two hours and returning to baseline by six hours.¹⁸

The two solvents that form the base of virtually every e-liquid, propylene glycol and vegetable glycerin, break down when heated into compounds including formaldehyde. Mouse studies have shown that inhaling the heated solvent aerosol alone, with no nicotine and no flavorings, significantly impaired the ability of blood vessels to relax. Formaldehyde generated from these solvents appeared to be the primary driver of that impairment.¹⁹ The researchers described this as a “universal flaw” of e-cigarettes, since every device that heats propylene glycol and vegetable glycerin will produce some formaldehyde regardless of what else is in the liquid.

Flavoring chemicals add another layer of concern. Laboratory tests on human aortic endothelial cells found that several popular flavoring compounds, including vanillin, menthol, cinnamaldehyde, and eugenol, triggered inflammation and impaired nitric oxide production at concentrations that did not kill the cells outright.²⁰ The practical implication is that switching to an unflavored or nicotine-free e-liquid does not eliminate the vascular risk, it just changes which components are doing the damage.

Young Vapers and Early Vascular Changes

One of the more concerning findings in recent years involves young, otherwise healthy e-cigarette users who have never smoked. A study comparing regular vapers to non-users found that the vapers already showed impaired microvascular function, with reduced blood-flow responses to heating and to natural vessel dilation. People who had vaped for more than three years also showed impairment in larger arteries, suggesting the damage progresses over time.²¹

Separately, researchers isolated tiny endothelial-derived particles from the blood of e-cigarette users and applied them to human brain microvascular cells in the lab. The particles reduced nitric oxide output, boosted production of a vessel-constricting molecule, and impaired the cells’ ability to release a protein involved in dissolving clots. The authors noted that these microvesicles could be a mediating factor linking e-cigarette use to an increased risk of stroke specifically in the brain’s small vessels.²² For young people who picked up vaping without ever smoking, these findings suggest that vascular damage can start accumulating well before traditional cardiovascular risk factors enter the picture.

Does Device Type or Nicotine Formulation Matter?

E-cigarettes are not a single product. They range from low-powered first-generation devices to high-wattage box mods that heat liquid at much higher temperatures. Higher temperatures generate more formaldehyde and other thermal-breakdown products, with one study measuring coil temperatures up to 460°C at higher power settings and finding a sharp jump in carbonyl emissions above about 270°C.²³ A preclinical study confirmed that higher wattage caused more vascular impairment in resistance arteries, with a 55 percent reduction in function at 30 watts compared with 32 percent at 5 watts.²⁴ Smaller arteries, including those in the brain, appeared more sensitive to damage than large ones.

Yet when researchers measured acute endothelial function in humans across a wide range of devices, flavors, and nicotine levels, they found that every device impaired blood vessel dilation to a similar degree, comparable to smoking a conventional cigarette. The degree of impairment did not correlate with nicotine concentration, suggesting a threshold effect where any meaningful exposure is enough to cause harm.²⁵

Nicotine formulation adds another wrinkle. Pod-style devices typically use nicotine salts, which deliver nicotine to the bloodstream faster than the freebase nicotine used in older devices. Animal research found that nicotine salts induced heart rhythm disturbances more potently than freebase nicotine, with the risk increasing at higher concentrations.²⁶ Cardiac arrhythmias can contribute to stroke through mechanisms like atrial fibrillation, which causes blood to pool and clot in the heart.

When Smokers Switch to Vaping

The picture changes when the comparison shifts from “vaping versus not using any tobacco” to “vaping versus continuing to smoke.” A systematic review with formal evidence grading found that smokers who quit by switching to e-cigarettes showed improvements in blood vessel dilation similar to those seen with other quit methods, and some improvements appeared within a month. The reviewers concluded that combustion, rather than nicotine itself, may be the primary driver of vascular impairment.²⁷

The young-adult study mentioned earlier found that people who exclusively vaped had lower odds of stroke than people who exclusively smoked cigarettes.⁵ These data do not mean vaping is safe in an absolute sense, but they do support the relative-risk framing that public health agencies have adopted: if a person is going to use one or the other, e-cigarettes appear to carry less vascular risk than combustible cigarettes. The problem is that “less harmful than cigarettes” is a very low bar, and it says nothing about the comparison that matters most for people who have never smoked.

What Vaping May Do After a Stroke

A less-discussed concern is whether vaping affects stroke outcomes and recovery. A 2025 animal study found that female rats exposed to e-cigarette vapor before an induced stroke had significantly worse neuronal survival across all examined brain regions compared with air-exposed females. The researchers also observed changes in brain metabolites linked to neurotransmitter production, and their earlier work had shown that e-cigarette exposure worsened post-stroke cognitive decline in young rats of both sexes.²⁸ While this is preclinical evidence, it suggests that continuing to vape after a stroke may not be neutral and could hinder recovery, a consideration that stroke survivors who vape should discuss with their doctors.

Cannabis Vaping and Stroke

When people hear “vaping,” they increasingly mean cannabis as well as nicotine. Cannabis use has its own association with acute cardiovascular events including ischemic stroke, sometimes in young people who have no traditional risk factors like high blood pressure or diabetes.²⁹ When cannabis is vaped rather than smoked, the user avoids combustion products but still inhales the heated solvent aerosol, the flavoring chemicals, and the cannabis compounds themselves. Very little research has looked specifically at the stroke risk of vaping cannabis, which means the vascular harms documented for nicotine vaping may apply on top of whatever risk the cannabis itself introduces. For people who vape both nicotine and cannabis products, the cumulative exposure to heated solvents, flavorings, and biologically active compounds is something no study has yet untangled.

No Nicotine Product Gets a Clean Bill of Health

A 2025 review in the European Heart Journal examined the cardiovascular effects of nicotine across all modern delivery systems, including e-cigarettes, heated-tobacco products, waterpipes, and oral nicotine pouches. The conclusion was blunt: while the products differ in toxicant exposure, all of them impair endothelial function, raise blood pressure, and promote the process that leads to hardened arteries, because nicotine itself is inherently toxic to the cardiovascular system.³⁰ That framing helps place e-cigarettes in context. They may produce fewer of the thousands of toxic chemicals found in cigarette smoke, and the evidence supports that they carry somewhat lower vascular risk than combustible cigarettes. But “lower risk” is not “no risk,” and the accumulating lab, animal, and human data make clear that vaping introduces a real and multifaceted set of insults to the blood vessels that supply the brain.